Issue Archive
August 2019 | Volume 18 | Issue 8
Editorials
Treating Acne With Topical Antibiotics
Letters to the Editor...
Read More
Original Articles
CME: Therapeutic Insights in Melasma and Hyperpigmentation Management
Melasma and postinflammatory hyperpigmentation (PIH) are the most common forms of dyschromia in patients with skin of color. Both are associated with a high psychological burden of disease. To exacerb...
Read MoreCombination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry
Importance: There are increasing options for systemic combination therapy for psoriasis but a lack of literature around the characteristics of patients who are started on these regimens.
O...
Read MorePrescribing Patterns Associated With Biologic Therapies for Psoriasis from a United States Medical Records Database
Introduction: Selecting a systemic therapy for patients with psoriasis is a complex process, based on a variety of factors including psoriasis severity, comorbid health conditions, access to care, and...
Read MoreA Review of Topical Corticosteroid Foams
Background: Topical corticosteroids are efficacious treatment options for multiple dermatoses. However, ointments and cream corticosteroid vehicles can be cumbersome to patients and may act as a barri...
Read MoreComparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients With Psoriasis
Psoriasis (PsO) is a common, systemic, chronic inflammatory disease characterized by key clinical symptoms, including itching, pain, and scaling, and is associated with substantial physical, psychosoc...
Read MoreTwo Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Foam Formulation of Halobetasol Propionate, 0.05% vs Its Vehicle in Adult Subjects With Plaque Psoriasis
Background: A novel foam formulation of halobetasol propionate, 0.05% (HBP-Foam) has been developed to treat plaque psoriasis in patients who prefer a thermostable topical foam with low application sh...
Read MoreUse of In-Office Preparations by Dermatologists for the Diagnosis of Cutaneous Fungal Infections
Cutaneous fungal infections account for millions of office visits per year, yet their varied presentations often lead to misdiagnosis. If dermatology clinics are Clinical Laboratory Improvement Amendm...
Read MoreEfficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials
Dupilumab, a monoclonal antibody that blocks the shared receptor subunit for interleukin (IL)-4 and IL-13, is currently approved for the treatment of adults with inadequately controlled moderate-to-se...
Read MoreHalobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy
Background: Psoriasis is a chronic, immune-mediated disease that varies widely in its clinical expression. Topical corticosteroids (TCS) are the mainstay of treatment. Long-term safety remains a conce...
Read More
Case Reports
Clinical Pathologic Mismatch in a TNF-α Inhibitor-Associated Drug Reaction
A 56-year-old Caucasian male with a history of chronic plaque psoriasis, primary sclerosing cholangitis status-post liver transplant on tacrolimus, and ulcerative colitis on infliximab developed a pro...
Read MoreOstraceous Psoriasis Presenting as Koebner Phenomenon in a Tattoo
Psoriasis is a common dermatologic condition with a variety of morphologic presentations. These variations include the less common hyperkeratotic form, psoriasis ostracea, defined as having pronounced...
Read MoreResolution of Guttate Psoriasis Plaques After One-time Administration of Guselkumab
Guttate psoriasis is an acute subtype of plaque psoriasis characterized by eruption of small, scaly plaques, and papules, 5 to 10 mm in size over the trunk and proximal extremities.1 It often arises i...
Read MoreThe Paradoxical Induction of Crohn’s Disease Following Treatment of Psoriatic Arthritis With Etanercept
Introduction: While psoriasis, psoriatic arthritis, and Crohn’s Disease (CD) all share a common central pathogenesis pathway and a wide overlap of treatment regime, discrepancies still exist and...
Read More
Supplements
SUPPLEMENT: Pre- and Post-Procedural Care Best Practices to Enhance Energy-Based Treatment Outcomes
Consumer demand for skin tightening and resurfacing procedures has accelerated during the last several years. Numerous energy-based treatment options have emerged for facial rejuvenation together with...
Read MoreARTICLE: Pre- and Post-Procedural Care Best Practices to Enhance Energy-Based Treatment Outcomes
Consumer demand for skin tightening and resurfacing procedures has accelerated during the last several years. Numerous energy-based treatment options have emerged for facial rejuvenation together with...
Read MoreFULL SUPPLEMENT: Do You Know the Most Complete, Targeted Biologic for Psoriasis? The Answer May Surprise You
When today’s dermatology residents were born, the concept of psoriasis as a systemic disease was relatively new. Early in the 1980s, topical therapy was the mainstay for medical management of th...
Read MoreARTICLE: Think You Know IL-17 Pathway? Think Again
When today’s dermatology residents were born, the concept of psoriasis as a systemic disease was relatively new. Early in the 1980s, topical therapy was the mainstay for medical management of th...
Read MoreARTICLE: IL-23 Versus IL-17 in the Pathogenesis of Psoriasis: There Is More to the Story Than IL-17A
Our understanding of psoriasis pathogenesis has evolved considerably. Cytokines within the TH1 and TH17 pathways have been found to be critical in psoriasis immunopathology. The TH17 pathway, which is...
Read More
